Leon Kircik, MD - What dermatoses are topical JAK inhibitors being investigated for?

John Koo, MD - Do topical JAK inhibitors and oral JAK inhibitors have similar rates of systemic...

John Koo, MD - Are topical JAK inhibitors, on the whole, more efficacious than superpotent topical..

Seemal Desai, MD - How do you compound your topical JAK inhibitors like tofacitinib or ruxolitinib?

Treatment of vitiligo with topical janus kinase inhibitor ruxolitinib

Atopic Dermatitis: A Deeper Look into JAK Inhibitors

Acne Scar Treatment

BIOLOGIC DRUGS And Your Skin #shorts

IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis | Peter Lio, MD

JAK Inhibitors - New FDA Approved Treatment!

JAK inhibitors for treating eczema

Year in Review: Perspectives on JAK Inhibitors for Atopic Dermatitis

Invited Speaker: Update on Jak Inhibitors For Vitiligo

Leon Kircik, MD - How do you discuss ruxolitinib cream safety concerns with your patients?

Multidisciplinary Conversations on JAK Inhibitors: A Live Social Media Event

10/18/22 JAK Inhibitors vs Biologics for Atopic Dermatitis

GRAPPA AAD 2023 Congress Highlights

02/13/24 "JAK" of All Trades, Master of Atopic Dermatitis?

New Treatments for AD for Infants and Children - Topical Therapies, Dr. Melinda Gooderham

Biologics for treating eczema